108994-73-6

Basic information

• Product Name: 5H-Cyclopenta[b]pyridine-3-carbonitrile,6,7-dihydro-(9CI)
• Synonyms: 5H-Cyclopenta[b]pyridine-3-carbonitrile,6,7-dihydro-(9CI);6,7-Dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile;6,7-Dihydro-5H-[1]pyrindine-3-carbonitrile
• CAS NO: 108994-73-6
• Molecular Formula: C9H8N2
• Molecular Weight: 144.17322
• Product Categories: PYRIDINE
• Mol File: 108994-73-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 259°C at 760 mmHg
• Flash Point: 99.4°C
• Appearance: /
• Density: 1.17g/cm³
• Vapor Pressure: 0.0133mmHg at 25°C
• Refractive Index: 1.581
• PKA: 2.74±0.20(Predicted)
• CAS DataBase Reference: 5H-Cyclopenta[b]pyridine-3-carbonitrile,6,7-dihydro-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 5H-Cyclopenta[b]pyridine-3-carbonitrile,6,7-dihydro-(9CI)(108994-73-6)
• EPA Substance Registry System: 5H-Cyclopenta[b]pyridine-3-carbonitrile,6,7-dihydro-(9CI)(108994-73-6)

Safety Data

• Hazardous Substances Data: 108994-73-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H8N2/c10-5-7-4-8-2-1-3-9(8)11-6-7/h4,6H,1-3H2

Upstream product

• 120-92-3 cyclopentanone 
• 108106-97-4 2-oxo-2,5,6,7-tetrahydro-3-cyano-1H-cyclopenta[b]pyridine-3-carbonitrile 
• 113124-08-6 2-bromo-6,7-dihydro-5H-1-pyrindine-3-carbonitrile 
• 126215-93-8 3-chloro-6,7-dihydro-5H-1-pyrindine 
• 126215-85-8 5-chloro-2-(pent-4-yn-1-yl)pyrimidine 

Relevant articles and documents

1,3-OXAZINES AS BACE 1 AND/OR BACE2 INHIBITORS

The present invention provides compounds of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present inv

1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS

The present invention relates to 1,4-Oxazepines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the pres

THERAPEUTIC AGENT FOR ANXIETY DISORDERS

Provided are an agent for the treatment and/or prophylaxis of an anxiety disorder comprising, as an active ingredient, a thiazole derivative represented by the formula (I) wherein R1 represents aryl or the like, and R2 represents pyridyl or the like, or a pharmaceutically acceptable salt thereof, and the like.